Search Results - "Hackman F"

Biotransformation research advances – 2023 year in review.

Authors: Khojasteh, S. Cyrus Argikar, Upendra A. Chatzopoulou, Maria et al.

Source: Drug Metabolism Reviews. Aug2024, Vol. 56 Issue 3, p190-222. 33p.

Biotransformation research advances – 2022 year in review.

Authors: Khojasteh, S. Cyrus Argikar, Upendra A. Cheruzel, Lionel et al.

Source: Drug Metabolism Reviews. Nov2023, Vol. 55 Issue 4, p301-342. 42p.

Long-term anti-SARS-CoV-2 antibody trajectories after neutralizing monoclonal antibody treatment.

Authors: Munroe, Elizabeth S. Grandits, Greg A. Hyzy, Robert C. et al.

Source: PLoS ONE. 6/18/2025, Vol. 20 Issue 6, p1-17. 17p.

Exploring covalent inhibitors of SARS-CoV-2 main protease: from peptidomimetics to novel scaffolds.

Authors: Atatreh, Noor Mahgoub, Radwa E. Ghattas, Mohammad A.

Source: Journal of Enzyme Inhibition & Medicinal Chemistry. Dec2025, Vol. 40 Issue 1, p1-26. 26p.

Intestinal permeability and immune‐inflammatory markers in patients with idiosyncratic drug‐induced liver injury, drug‐induced steatosis and metabolic dysfunction–associated steatotic liver disease (MASLD).

Authors: Di Zeo‐Sánchez, Daniel E. Díaz‐Alberola, Irene Pinazo‐Bandera, José María et al.

Source: British Journal of Pharmacology. Nov2025, Vol. 182 Issue 21, p5303-5316. 14p.

Diagnostic and Prognostic Biomarkers for Sepsis‐Associated Liver Injury: Current Status and Future Perspectives.

Authors: Cai, Yao-zheng Chen, Jiang-tao Fang, Le-xin et al.

Source: Gastroenterology Research & Practice. 3/16/2026, Vol. 2026, p1-8. 8p.

Is Antiviral Treatment with Remdesivir at the Acute Phase of SARS-CoV-2 Infection Effective for Decreasing the Risk of Long-Lasting Post-COVID Symptoms?

Authors: Fernández-de-las-Peñas, César Franco-Moreno, Anabel Ruiz-Ruigómez, María et al.

Source: Viruses (1999-4915). Jun2024, Vol. 16 Issue 6, p947. 10p.

Pregabalin in patients with post‐traumatic peripheral neuropathic pain: A meta‐analysis of randomized controlled trials.

Authors: Maleki, Mohsen Saheban Zamani, Zahra Amiri, Roya et al.

Source: Pain Practice. Jul2023, Vol. 23 Issue 6, p595-602. 8p. 1 Diagram, 3 Charts, 1 Graph.

Subjects: Peripheral nerve injuries, Pregabalin, Drug efficacy, Online information services, Medical databases, Meta-analysis, Confidence intervals, Neuralgia, Systematic reviews, Patients, Treatment effectiveness, Randomized controlled trials, Placebos, Emergency medical services, Descriptive statistics, MEDLINE, Data analysis software, Patient safety

Serum glutamate dehydrogenase activity enables sensitive and specific diagnosis of hepatocellular injury in humans.

Authors: Aubrecht, Jiri Potter, David Sauer, John Michael et al.

Source: Toxicological Sciences. Feb2025, Vol. 203 Issue 2, p171-180. 10p.

Real-World Experience of the Comparative Effectiveness and Safety of Molnupiravir and Nirmatrelvir/Ritonavir in High-Risk Patients with COVID-19 in a Community Setting.

Authors: Mutoh, Yoshikazu Umemura, Takumi Nishikawa, Takeshi et al.

Source: Viruses (1999-4915). Mar2023, Vol. 15 Issue 3, p811. 10p.

Rapid RP-HPLC-UV determination of molnupiravir, nirmatrelvir, and remdesivir alone, in pharmaceutical mixture and plasma.

Authors: Abd-Elmegid, Osama A. Zaky, Mounir Elgendy, Khaled

Source: Discover Chemistry. Dec2025, Vol. 2 Issue 1, p1-16. 16p.

Comment on "Pregabalin in patients with post‐traumatic peripheral neuropathic pain: A meta‐analysis of randomized controlled trials".

Authors: Chen, I‐Wen Kao, Chia‐Li Hung, Kuo‐Chuan

Source: Pain Practice. Jul2024, Vol. 24 Issue 6, p869-870. 2p.

Subjects: Peripheral nerve injuries, Neuralgia, Patient safety, Research bias, Drug efficacy, Pregabalin

Factors influencing Nirmatrelvir/Ritonavir concentration in patients with COVID-19.

Authors: Xu, Ping Zhang, Lijun Wu, Qingguo

Source: BMC Infectious Diseases. 12/18/2024, Vol. 24 Issue 1, p1-7. 7p.

Drug-Induced Liver Injury: Role of Circulating Liver-Specific microRNAs and Keratin-18.

Authors: Cardin, Romilda Bizzaro, Debora Russo, Francesco Paolo et al.

Source: Gastroenterology Insights. Dec2024, Vol. 15 Issue 4, p1093-1105. 13p.

Population pharmacokinetics and pharmacodynamics of nirmatrelvir in Chinese patients with COVID‐19.

Authors: Zeng, Liyan Chen, Rui Jiang, Xuhua et al.

Source: Fundamental & Clinical Pharmacology. Aug2024, Vol. 38 Issue 4, p767-779. 13p.

Roots of Lithospermum erythrorhizon Alleviated Ovalbumin-Induced Allergic Rhinitis and IgE-triggered Degranulation of RBL-2H3 Cells.

Authors: Kang, Tae Kyeom Le, Tam Thi Choi, Su-Young et al.

Source: Applied Sciences (2076-3417); Jun2022, Vol. 12 Issue 12, p6116, 12p

SARS-CoV-2 Infection and Antiviral Strategies: Advances and Limitations.

Authors: Soares, Vinicius Cardoso Moreira, Isabela Batista Gonçalves Dias, Suelen Silva Gomes

Source: Viruses (1999-4915). Aug2025, Vol. 17 Issue 8, p1064. 24p.

Cytokeratin-18 is a sensitive biomarker of alanine transaminase increase in a placebo-controlled, randomized, crossover trial of therapeutic paracetamol dosing (PATH-BP biomarker substudy).

Authors: Scullion, Kathleen M MacIntyre, Iain M Sloan-Dennison, Sian et al.

Source: Toxicological Sciences. Jun2024, Vol. 199 Issue 2, p203-209. 7p.

Meeting report of the 4th European biotransformation workshop.

Authors: Walles, M. Pähler, A. Isin, E.M. et al.

Source: Xenobiotica. May2024, Vol. 54 Issue 5, p257-262. 6p.

Serum Levels of miR-122-5p and miR-125a-5p Predict Hepatotoxicity Occurrence in Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation.

Authors: Mikulski, Damian Kościelny, Kacper Dróżdż, Izabela et al.

Source: International Journal of Molecular Sciences. Apr2024, Vol. 25 Issue 8, p4355. 14p.